News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2022 Shelley Wood September 01, 2022
News Conference News ESC 2022 P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER Todd Neale August 29, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022
News Daily News LAA Occlusion With Watchman Provides Good Early Results in China Todd Neale June 07, 2022
News Conference News EuroPCR 2022 Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT Yael L. Maxwell May 17, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2022 Shelley Wood May 02, 2022
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2022 Bentracimab Swiftly Reverses Ticagrelor, Platelet-Function Study Affirms Todd Neale April 02, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Daily News Early Aspirin Tied to Less In-Hospital Mortality in Moderate COVID-19 Todd Neale March 25, 2022
News Daily News REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 Todd Neale March 22, 2022
News Daily News Before and After PCI, Women Have Poorer Health Status Than Men L.A. McKeown January 28, 2022
News Daily News Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis Yael L. Maxwell December 24, 2021
News Daily News Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients Shelley Wood December 22, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data Yael L. Maxwell November 15, 2021